Seladelpar Could 'Raise the Bar' in PBC Treatment
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.
Source: medscape.com
Par Agonists News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Par Agonists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Par Agonists Today - Breaking & Trending Today
Promising Phase 2 Results for Novel Oral Alzheimer's Drug
An investigational dual PPAR agonist modifies Alzheimer's pathology and shows cognitive benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early data show.
Source: medscape.com
Novel Drug Lanifibranor Promising for NASH
Lanifibranor, a first-in-class pan-PPAR agonist, hits the primary and key secondary end points in a phase 2b trial of patients with noncirrhotic, highly active nonalcoholic steatohepatitis.
Source: medscape.com